EHR · Practice management · D2E · D2C

Strategy for
Digital.

We support digital health and health tech companies as they develop and scale new digitally enabled services and products for patients, providers, payers, and employers. We focus on strategy projects from product-market fit and business models to growth and corporate development.

FEATURED PERSPECTIVE

  • Providers , 
  • Digital

Survivorship Is Expanding Cancer Care — How Are Oncology Providers Responding?

Read the analysis →

"The time is now for cancer centers to decide which model best aligns with their staffing, patient mix and institutional structure."

— Recon analysis

Survivorship Is Expanding Cancer Care — How Are Oncology Providers Responding?

  • Providers , 
  • Digital
Survivorship care is increasingly pivotal to cancer care delivery and …

Read more

Stylized representation of digital health

Keys to harnessing the value of digital biomarkers in clinical trials

  • Biopharma , 
  • Medtech , 
  • Digital , 
For years, digital biomarkers have seemed like a promising way to tran…

Read more

Artificial Intelligence for Pipeline Discovery and Beyond

  • Biopharma , 
  • Digital , 
The biopharma industry is known for its high risk and potential high r…

Read more

SELECTED CASE STUDIES

How we've helped health tech clients

Representative engagements, anonymized. Each pairs deep sector knowledge with rigorous, structured analysis.

Direct-to-employer care growth strategy

A direct-to-employer primary care provider had outgrown word-of-mouth selling and its leadership and board disagreed on where the next phase of growth should come from.

Employer segmentation and targeting

Device market entry strategy

An early-stage technology could digitize a large analog device market but needed the board aligned on which market to enter first, and on what terms to engage incumbents, before its Series A ran out.

Digital diagnostic business case

Urgent care acquisition assessment

A large healthcare provider was weighing entry into urgent care through acquisition and needed to know what a target chain was actually worth to them.

Urgent care M&A valuation